Subcutaneous Amivantamab in Practice: Clinical Insights and AE Management

Panelists discuss how the availability of subcutaneous amivantamab influences nursing approaches to patient care and education, with Squires sharing strategies for ensuring patients understand the new administration method and preparing them for treatment.

EP: 1.EGFR-Targeted Therapies in NSCLC: IV vs Subcutaneous Administration

Now Viewing

EP: 2.Subcutaneous Amivantamab in Practice: Clinical Insights and AE Management

EP: 3.Clinical Decision-Making and Sequencing Strategies in EGFR-Mutated NSCLC

EP: 4.Patient-Centered Approaches in EGFR-Mutated NSCLC

Video content above is prompted by the following:

From a nursing perspective, how does the availability of subcutaneous amivantamab influence your approach to patient care and education?

Recent Videos